Francesco Di Raimondo

Dottorando

Struttura:

E-mail:

Pubblicazioni

Titolo	Pubblicato in	Anno
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data	HEMATOLOGICAL ONCOLOGY	2020
On the road to treatment-free remission in chronic myeloid leukemia: what about `the others'?	EXPERT REVIEW OF ANTICANCER THERAPY	2020